Clinical Trials Logo

Clinical Trial Summary

The urinary elimination kinetics of glucocorticoids after intra-articular injection is very poorly documented. It is estimated that glucocorticoids may be present in the urine up to 6 weeks after intra-articular injection. However, this is not supported by any scientific literature. Despite this lack of evidence, in doping control practice, any presence of glucocorticoids in urine is accepted when the athlete provides evidence of an intra-articular injection that took place less than 6 weeks prior to the doping control. Many doping cases are open to challenge because they are based solely on measurements of prednisolone concentrations and its blood esterase product, prednisone. In order to demonstrate the use of prednisolone for doping purposes (systemic and not intra-articular use), it is therefore necessary to know the urinary elimination kinetics of prednisolone and prednisone, as well as the evolution of the concentration ratio between these 2 molecules.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05300490
Study type Observational
Source University Hospital, Strasbourg, France
Contact
Status Withdrawn
Phase
Start date May 2023
Completion date January 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04840147 - A Comparison of JointRep® and Microfracture in Repair of Cartilage Lesions on the Femoral Condyle or Trochlea, N/A
Recruiting NCT03588975 - A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee Phase 3
Completed NCT01076673 - Effect of Autologous Peripheral Blood Stem Cell Treatment on Articular Cartilage Regeneration Phase 2
Terminated NCT03678948 - Radiofrequency-Based Debridement vs. Mechanical Debridement for the Treatment of Articular Cartilage Lesions N/A
Terminated NCT05082831 - Human ECM Implanted Within Microfracture Interstices & the Cartilage Defect in the Knee to Regenerate Hyaline Cartilage Phase 1
Recruiting NCT05924763 - The Clinical Outcome of BiCRI in the Treatment of Chondral and Osteochondral Lesions N/A
Completed NCT02118519 - Mesenchymal Stem Cells in Knee Cartilage Injuries Phase 2
Active, not recruiting NCT02524509 - the Safety and Efficacy Evaluation of Chondron Compared With Mircrofracture of Knee Phase 4
Completed NCT01576159 - Serum Cartilage Oligomeric Matrix Protein Levels After 12 Weeks of Different Exercises Phase 0
Completed NCT03101163 - Efficacy and Safety Study of Intra-Articular Injections of Autologous Peripheral Blood Stem Cells Following Subchondral Drilling Surgery for the Treatment of Articular Cartilage Injury in the Knee Phase 2